These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6083911)

  • 21. Immunologic study of fibrinogen and its split products in venous thrombosis.
    Sova J
    Acta Univ Carol Med Monogr; 1972; 52():173-9. PubMed ID: 4593289
    [No Abstract]   [Full Text] [Related]  

  • 22. Plasma fibrinogen, fibrinolytic activity and serum fibrinogen/fibrin degradation products in ischaemic heart disease.
    Dube B; Somani PN; Tripathi GK; Dube RK; Bhattacharya SK
    J Assoc Physicians India; 1985 Dec; 33(12):784-5, 787. PubMed ID: 3837002
    [No Abstract]   [Full Text] [Related]  

  • 23. [Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction].
    Halbmayer WM; Mannhalter C; Feichtinger C; Rubi K; Fischer M
    Wien Med Wochenschr; 1993; 143(2):43-50. PubMed ID: 8488686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are fibrin-related markers useful for the diagnosis of thrombosis?
    Wada H; Sakuragawa N
    Semin Thromb Hemost; 2008 Feb; 34(1):33-8. PubMed ID: 18393141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein C and S deficiency, thrombophilia, and hypofibrinolysis: pathophysiologic causes of Legg-Perthes disease.
    Glueck CJ; Glueck HI; Greenfield D; Freiberg R; Kahn A; Hamer T; Stroop D; Tracy T
    Pediatr Res; 1994 Apr; 35(4 Pt 1):383-8. PubMed ID: 8047373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secretory response of the vessel wall to DDAVP and venous occlusion in von Willebrand's disease.
    Bykowska K; Letowska M; Sabliński J; Binder BR; Kopeć M; Lopaciuk S
    Acta Haematol Pol; 1994; 25(3):261-8. PubMed ID: 7992599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
    Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
    Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies--a crucial role for acquired free protein S deficiency.
    Ames PR; Tommasino C; Iannaccone L; Brillante M; Cimino R; Brancaccio V
    Thromb Haemost; 1996 Aug; 76(2):190-4. PubMed ID: 8865529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue factor pathway inhibitor relates to fibrin degradation in patients with acute deep venous thrombosis.
    Sidelmann JJ; Bladbjerg EM; Gram J; Münster AM; Jespersen J
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):405-9. PubMed ID: 18600090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Assay of antithrombin III and soluble fibrin complexes in the study of blood thrombophilia (author's transl)].
    Colombo LA; Corberi OM; Finzi M; Rossi G
    Chir Ital; 1979 Aug; 31(4):650-61. PubMed ID: 553732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical usefulness of D-dimer: evaluation during fibrinolytic treatment of venous thrombosis or myocardial infarction.
    Simank HG; Simon M; Bode C; Zimmermann R; Kübler W; Weber E
    Thromb Res; 1989 Nov; 56(4):541-6. PubMed ID: 2609291
    [No Abstract]   [Full Text] [Related]  

  • 32. The John Charnley Award. Thrombogenesis during total hip arthroplasty.
    Sharrock NE; Go G; Harpel PC; Ranawat CS; Sculco TP; Salvati EA
    Clin Orthop Relat Res; 1995 Oct; (319):16-27. PubMed ID: 7554626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The inability of propranolol and aspirin to inhibit the response of fibrinolytic activity and factor VIII-antigen to infusion of DDAVP.
    Brommer EJ; Derkx FH; Barrett-Bergshoeff MM; Schalekamp MA
    Thromb Haemost; 1984 Feb; 51(1):42-4. PubMed ID: 6426080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM Trial.
    Christersson C; Oldgren J; Bylock A; Siegbahn A; Wallentin L
    Eur Heart J; 2007 Mar; 28(6):692-8. PubMed ID: 17314111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered endothelial function following the Fontan procedure.
    Binotto MA; Maeda NY; Lopes AA
    Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
    Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo assessment of thrombosis and fibrinolysis during acute myocardial infarction.
    Jaffe AS; Eisenberg PR; Wilner GD
    Prog Hematol; 1987; 15():71-89. PubMed ID: 3332392
    [No Abstract]   [Full Text] [Related]  

  • 38. Premature compared with late onset of coronary artery disease: young patients show a severe defect in fibrinolytic response to venous occlusion.
    Speidl WS; Nikfardjam M; Niessner A; Jordanova N; Zorn G; Maurer G; Schreiber W; Wojta J; Huber K
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):165-71. PubMed ID: 17287634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced plasma fibrinolytic capacity as a potential risk factor for a first myocardial infarction in young men.
    Meltzer ME; Doggen CJ; de Groot PG; Rosendaal FR; Lisman T
    Br J Haematol; 2009 Apr; 145(1):121-7. PubMed ID: 19170679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms--the Leiden Thrombophilia Study (LETS).
    Koster T; Rosendaal FR; Reitsma PH; van der Velden PA; Briët E; Vandenbroucke JP
    Thromb Haemost; 1994 Jun; 71(6):719-22. PubMed ID: 7974338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.